Drug-induced liver injury (DILI), including herbal and dietary supplement hepatotoxicity, is often passed lightly; however, it can lead to the requirement of a liver transplant or may even cause death because of liver failure. Recently, the American College of Gastroenterology, Chinese Society of Hepatology and European Association for the Study of the Liver guidelines for the diagnosis and treatment of DILI have been established, and they will be helpful for guiding clinical treatment decisions. Roussel Uclaf Causality Assessment Method scoring is the most commonly used method to diagnose DILI; however, it has some limitations, such as poor validity and reproducibility. Recently, studies on new biomarkers have been actively carried out, which will help diagnose DILI and predict the prognosis of DILI. It is expected that the development of new therapies such as autophagy inducers and various other technologies of the fourth industrial revolution will be applicable to DILI research.
Citations
Citations to this article as recorded by
Drug-Induced Liver Injury Due to Doxycycline: A Case Report and Review of Literature Nikola Nikolajevic, Milan Nikolajevic, Ivana Pantic, Bojan Korica, Magdalena Kotseva, Tamara Alempijevic, Dorde Jevtic, Cristian I Madrid, Igor Dumic Cureus.2024;[Epub] CrossRef
Drug-resistant epilepsy and its selected complications in children Magdalena Knopek, Joanna Iwanicka, Grzegorz Boryczka Annales Academiae Medicae Silesiensis.2024; 78: 127. CrossRef
An Open-Label Extension Study Assessing the Long-Term Safety and Efficacy of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder Ann Childress, Andrew J. Cutler, Lenard A. Adler, Nicholas Fry, Kobby Asubonteng, Zulane Maldonado-Cruz, Andrea Formella, Jonathan Rubin CNS Drugs.2024; 38(11): 891. CrossRef
Severe liver injury induced by minocycline in hepatitis B patient: a Case Report Ran Wang, Yun Li, Xue Xia Frontiers in Pharmacology.2024;[Epub] CrossRef
Liver Injury in Favipiravir-Treated COVID-19 Patients: Retrospective Single-Center Cohort Study Amal Oweid Almutairi, Mahmoud Zaki El-Readi, Mohammad Althubiti, Yosra Zakariyya Alhindi, Nahla Ayoub, Abdullah R. Alzahrani, Saeed S. Al-Ghamdi, Safaa Yehia Eid Tropical Medicine and Infectious Disease.2023; 8(2): 129. CrossRef
Hepatotoxic Components Effect of Chebulae Fructus and Associated Molecular Mechanism by Integrated Transcriptome and Molecular Docking Liwen Ai, Fan Yang, Wanjun Hu, Liyang Guo, Weixue Liu, Xuexue Xue, Lulu Li, Zunlai Sheng Molecules.2023; 28(8): 3427. CrossRef
Systematic Review of Safety of Selective Androgen Receptor Modulators in Healthy Adults: Implications for Recreational Users Jonathan D. Vignali, Kevin C. Pak, Holly R. Beverley, Jesse P. DeLuca, John W. Downs, Adrian T. Kress, Brett W. Sadowski, Daniel J. Selig Journal of Xenobiotics.2023; 13(2): 218. CrossRef
Antitubercular drugs induced liver injury: an updated insight into molecular mechanisms Devaraj Ezhilarasan Drug Metabolism Reviews.2023; 55(3): 239. CrossRef
Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use Rolf Teschke, Gaby Danan International Journal of Molecular Sciences.2023; 24(13): 10855. CrossRef
Application of artificial intelligence and machine learning in early detection of adverse drug reactions (ADRs) and drug-induced toxicity Siyun Yang, Supratik Kar Artificial Intelligence Chemistry.2023; 1(2): 100011. CrossRef
Rifampicin-induced ER stress and excessive cytoplasmic vacuolization instigate hepatotoxicity via alternate programmed cell death paraptosis in vitro and in vivo KM Kainat, Mohammad Imran Ansari, Nuzhat Bano, Pankaj Ramji Jagdale, Anjaneya Ayanur, Mahadeo Kumar, Pradeep Kumar Sharma Life Sciences.2023; 333: 122164. CrossRef
Establishment of a Stable Acute Drug-Induced Liver Injury Mouse Model by Sodium Cyclamate Quan Zhou, Zhongtian Peng, Xialing Huang Journal of Inflammation Research.2022; Volume 15: 1599. CrossRef
Mitochondrial toxicants in Xian-Ling-Gu-Bao induce liver injury by regulating the PI3K/mTOR signaling pathway: an in vitro study Shujuan Piao, Hongwei Lin, Xia Tao, Wansheng Chen BMC Complementary Medicine and Therapies.2022;[Epub] CrossRef
Kratom-Induced Liver Injury: A Case Series and Clinical Implications Mahesh Botejue, Gurjot Walia, Omar Shahin, Jyotsna Sharma, Rasiq Zackria Cureus.2021;[Epub] CrossRef
Colestasis inducida por anabólicos: reporte de caso y revisión de la literatura Diana Lizeth Cabrera-Rojas, Juliana Soto-Cardona, Jorge Luis Toro-Molina, Juan Camilo Pérez-Cadavid, Juan Ignacio Marín-Zuluaga Hepatología.2021; : 273. CrossRef
Hepatic drug-metabolizing enzymes and drug transporters in Wilson’s disease patients with liver failure Sylwia Szeląg-Pieniek, Stefan Oswald, Mariola Post, Joanna Łapczuk-Romańska, Marek Droździk, Mateusz Kurzawski Pharmacological Reports.2021; 73(5): 1427. CrossRef
Prediction of Drug-Induced Liver Toxicity Using SVM and Optimal Descriptor Sets Keerthana Jaganathan, Hilal Tayara, Kil To Chong International Journal of Molecular Sciences.2021; 22(15): 8073. CrossRef
Five Constituents Contributed to the Psoraleae Fructus-Induced Hepatotoxicity via Mitochondrial Dysfunction and Apoptosis Zhaojuan Guo, Pin Li, Chunguo Wang, Qianjun Kang, Can Tu, Bingqian Jiang, Jingxuan Zhang, Weiling Wang, Ting Wang Frontiers in Pharmacology.2021;[Epub] CrossRef
Changes in Liver Function Test Results after Korean Medicine Treatment in Patients of a Korean Medicine Hospital: A Retrospective Chart Review Min Young Yim, Han Byeol Park, Jae Soo Kim, Hyun Jong Lee, Sung Chul Lim, Yun Kyu Lee Korean Journal of Acupuncture.2021; 38(4): 275. CrossRef
Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases Rolf Teschke, Yun Zhu, Jing Jing Journal of Clinical and Translational Hepatology.2020; 8(2): 200. CrossRef
Embarazo y lesión hepática inducida por medicamentos. Reporte de un caso y revisión de la literatura Christian Labrador-López, Martín Garzón-Olarte, Rodrigo Daza-Fernández, Julián Martínez-Marín, Jorge Lizarazo-Rodríguez, Juan Carlos Molano-Villa, Juan Carlos Marulanda-Gómez, Mario Rey-Tovar Hepatología.2020; : 157. CrossRef
Imatinib mesylate is currently used as the first-line treatment for metastatic gastrointestinal stromal tumors (GISTs). Imatinib-induced hepatotoxicity in patients with GIST is very rare. Its features vary from subclinical elevation of serum aminotransferase to clinically apparent acute hepatitis, which is associated with immunologic reactions. Imatinib-induced hepatotoxicity with autoimmune-like features can be treated by the discontinuation of imatinib mesylate and the administration of oral steroids. Here, we report a case of late-onset imatinib-induced hepatitis with autoimmune-like features in a patient with metastatic GIST, which was improved by oral corticosteroids.
Citations
Citations to this article as recorded by
The prevalence of hepatic and thyroid toxicity associated with imatinib treatment of chronic myeloid leukaemia: a systematic review Mansour Tobaiqy, Nawal Helmi, Katie MacLure, Sylvia Saade International Journal of Clinical Pharmacy.2024; 46(2): 368. CrossRef
Investigation of the role of NLRP3 inflammasome activation in new-generation BCR-ABL1 tyrosine kinase inhibitors-induced hepatotoxicity Ege Arzuk Toxicology Letters.2024; 400: 71. CrossRef
Antioxidant-Based Preventive Effect of Phytochemicals on Anticancer Drug-Induced Hepatotoxicity Ji Eon Park, Chi-Hoon Ahn, Hyo-Jung Lee, Deok Yong Sim, Su Yeon Park, Bonglee Kim, Bum Sang Shim, Dae Young Lee, Sung-Hoon Kim Antioxidants & Redox Signaling.2023; 38(16-18): 1101. CrossRef